m6A Target Gene Information
General Information of the m6A Target Gene (ID: M6ATAR00541)
Full List of m6A Methylation Regulator of This Target Gene and Corresponding Disease/Drug Response(s)
BPTF
can be regulated by the following regulator(s), and cause disease/drug response(s). You can browse detail information of regulator(s) or disease/drug response(s).
Browse Regulator
Browse Disease
Methyltransferase-like 14 (METTL14) [WRITER]
Representative RNA-seq result indicating the expression of this target gene regulated by METTL14 | ||
Cell Line | mouse embryonic stem cells | Mus musculus |
Treatment: METTL14-/- ESCs
Control: Wild type ESCs
|
GSE145309 | |
Regulation |
|
logFC: 9.11E-01 p-value: 2.73E-20 |
More Results | Click to View More RNA-seq Results |
In total 1 item(s) under this regulator | ||||
Experiment 1 Reporting the m6A Methylation Regulator of This Target Gene | [1] | |||
Response Summary | METTL14 deficiency promoted RCC metastasis in vitro and in vivo. Mechanistically, METTL14-mediated m6A modification negatively regulated the mRNA stability of Nucleosome-remodeling factor subunit BPTF (BPTF) and depended on BPTF to drive lung metastasis. | |||
Target Regulation | Down regulation | |||
Responsed Disease | Renal cell carcinoma | ICD-11: 2C90 | ||
Pathway Response | Glycerolipid metabolism | hsa00561 | ||
Cell Process | Glycolysis | |||
In-vitro Model | RenCa | Mouse kidney carcinoma | Mus musculus | CVCL_2174 |
Caki-1 | Clear cell renal cell carcinoma | Homo sapiens | CVCL_0234 | |
ACHN | Papillary renal cell carcinoma | Homo sapiens | CVCL_1067 | |
786-O | Renal cell carcinoma | Homo sapiens | CVCL_1051 | |
In-vivo Model | To generate a highly metastatic orthotopic xenograft model, 1 × 105 luciferase-expressing Renca cells (Luc-Renca) in 25 ul of 2:1 (v/v) PBS:Matrigel were injected into the right sub-renal capsule of the kidney of BALB/c mice (4 mice/group). | |||
Renal cell carcinoma [ICD-11: 2C90]
In total 1 item(s) under this disease | ||||
Experiment 1 Reporting the m6A-centered Disease Response | [1] | |||
Response Summary | METTL14 deficiency promoted RCC metastasis in vitro and in vivo. Mechanistically, METTL14-mediated m6A modification negatively regulated the mRNA stability of Nucleosome-remodeling factor subunit BPTF (BPTF) and depended on BPTF to drive lung metastasis. | |||
Responsed Disease | Renal cell carcinoma [ICD-11: 2C90] | |||
Target Regulator | Methyltransferase-like 14 (METTL14) | WRITER | ||
Target Regulation | Down regulation | |||
Pathway Response | Glycerolipid metabolism | hsa00561 | ||
Cell Process | Glycolysis | |||
In-vitro Model | RenCa | Mouse kidney carcinoma | Mus musculus | CVCL_2174 |
Caki-1 | Clear cell renal cell carcinoma | Homo sapiens | CVCL_0234 | |
ACHN | Papillary renal cell carcinoma | Homo sapiens | CVCL_1067 | |
786-O | Renal cell carcinoma | Homo sapiens | CVCL_1051 | |
In-vivo Model | To generate a highly metastatic orthotopic xenograft model, 1 × 105 luciferase-expressing Renca cells (Luc-Renca) in 25 ul of 2:1 (v/v) PBS:Matrigel were injected into the right sub-renal capsule of the kidney of BALB/c mice (4 mice/group). | |||